United States Federal Circuit
Shire Development, LLC v. Watson Pharmaceuticals, Inc., 2013-1409
Judgment for plaintiff finding that defendant's product infringed plaintiff's patent, which claims a controlled-release oral pharmaceutical composition for treating inflammatory bowel diseases, is reversed and remanded, where the district court's constructions of "inner lipophilic matrix" and "outer hydrophilic matrix" impermissibly broaden the ordinary meaning of the terms.
Appellate Information
- Decided 03/28/2014
- Published 03/28/2014
Judges
- HUGHES
Court
- United States Federal Circuit